2nd Quarter - Report — CEPHEID for CEPHEID (2020)

Firm

CEPHEID

Client

CEPHEID

Income

—

Expenses

$76,500

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6102/S. 3404 the Verifying Accurate and Leading-edge IVCT Development Act (VALID), H.R. 266, Paycheck Protection Program and Health Care Enhancement Act; S. 4198 Affordable Coronavirus Testing Act; issues related to diagnostic testing

Lobbyist	Covered position, as disclosed
MICHELE M SCHOONMAKER	—
ANGELA STEWART New	Legislative Counsel, Senator John W. Warner (R-VA)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6102 (116th), S. 3404 (116th), H.R. 266 (116th), S. 4198 (116th)

Medicare/Medicaid MMM

Issues relating to PAMA implementation (Protecting Access to Medicare Act); S. 4198, Affordable Coronavirus testing Act; issues related to diagnostics testing

Lobbyist	Covered position, as disclosed
MICHELE M SCHOONMAKER	—
ANGELA STEWART New	Legislative Counsel, Senator John W. Warner (R-VA)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4198 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.